Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.63 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.63 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.63 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.63 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.63 |
| ▸ | PPARG | P37231 | 2/20 | 0.63 |
| ▸ | EP300 | Q09472 | 2/20 | 0.63 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.63 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.63 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.63 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.55 |
| ▸ | F7 | P08709 | 2/20 | 0.55 |
| ▸ | F3 | P13726 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | ECE1 | P42892 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2047267 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL112984 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL168815 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL2044839 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL2046701 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL6435540 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL6436998 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL5272270 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL1003208 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 | |
| SCHEMBL9410786 | 1.00 | BID (0.63) | BIDMCL1KAT8PPARABCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1933807-B1 | COSMETIC PRODUCT FOR THE TREATMENT OF SCALP | CUTRIN OY (FI) | 2015-11-04 | — | — | EP | claimed |
| EP-1176949-B1 | LIPID PARTICLES ON THE BASIS OF MIXTURES OF LIQUID AND SOLID LIPIDS AND METHOD FOR PRODUCING SAME | PHARMASOL GMBH (DE) | 2014-12-10 | — | — | EP | claimed |
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | SOL-GEL TECHNOLOGIES LTD. (IL) | 2012-12-20 | — | — | US | claimed |
| EP-2324812-A2 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | Sol-Gel Technologies Ltd. (IL) | 2011-05-25 | — | — | EP | claimed |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | SOL-GEL TECHNOLOGIES LTD. (IL) | 2005-02-17 | — | — | US | claimed |
| EP-1446086-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | Sol-Gel Technologies Ltd. (IL) | 2004-08-18 | — | — | EP | claimed |
| JP-2003534249-A | — | — | 2003-11-18 | — | — | JP | claimed |
| EP-1335693-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS | Sol-Gel Technologies Ltd. (IL) | 2003-08-20 | — | — | EP | claimed |
| WO-2003039510-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | SOL-GEL TECHNOLOGIES LTD. (IL) | 2003-05-15 | — | — | WO | claimed |
| WO-2003034979-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2003-05-01 | — | — | WO | claimed |
| EP-0987011-B1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| EP-0886517-B1 | METHOD FOR REDUCING SKIN OILS AND GREASE | UNILEVER PLC (GB) | 2002-07-03 | — | — | EP | claimed |
| US-20020064541-A1 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | SOL-GEL TECHNOLOGIES LTD. (IL) | 2002-05-30 | — | — | US | claimed |
| EP-0881896-B1 | SKIN TREATMENT WITH SALICYLIC ACID ESTERS AND RETINOIDS | FD MAN INC (US) | 2002-05-02 | — | — | EP | claimed |
| EP-1176949-A2 | LIPID PARTICLES ON THE BASIS OF MIXTURES OF LIQUID AND SOLID LIPIDS AND METHOD FOR PRODUCING SAME | Pharmasol GmbH (DE) | 2002-02-06 | — | — | EP | claimed |
| WO-2001080823-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TROPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2001-11-01 | — | — | WO | claimed |
| WO-2000067728-A2 | LIPID PARTICLES ON THE BASIS OF MIXTURES OF LIQUID AND SOLID LIPIDS AND METHOD FOR PRODUCING SAME | PHARMASOL GMBH (DE) | 2000-11-16 | — | — | WO | claimed |
| EP-4322910-B1 | RETINOL OIL FORMULATION | DSM IP ASSETS BV (NL) | 2026-01-14 | — | — | EP | disclosed |
| EP-0839840-A2 | Novel succinimide compound and method for producing it, lubricating oil additive comprising the compound, and lubricating oil composition comprising the compound for diesel engines | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-05-06 | — | — | EP | disclosed |
| EP-0807429-A1 | Cosmetic composition with retinol unsaturated fatty acid esters | UNILEVER PLC (GB) | 1997-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | GNG2, COG5, SQLE | BID 4867/4885MCL1 2927/4885KAT8 1256/4885 |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | GNG2, COG5, SQLE | BID 4867/4885MCL1 2927/4885KAT8 1256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.